These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28220299)

  • 21. ddPCR Analysis Reveals BRAF V600E Mutations Are Infrequent in Isolated Pituitary Langerhans Cell Histiocytosis Patients.
    Nellan A; Bodlak A; Mirsky DM; Mulcahy Levy J; Garrington TP; Foreman NK; Gilani A; Hayashi M
    J Neuropathol Exp Neurol; 2020 Dec; 79(12):1313-1319. PubMed ID: 32930721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Prevalence of
    Liu X; Zhang Y; Zhou CX
    Int J Surg Pathol; 2019 Dec; 27(8):836-843. PubMed ID: 31203679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.
    Uguen A; Talagas M; Costa S; Samaison L; Paule L; Alavi Z; De Braekeleer M; Le Marechal C; Marcorelles P
    Diagn Pathol; 2015 Jul; 10():121. PubMed ID: 26204954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of MAP2K1, TP53, and U2AF1 Mutations in BRAF-mutated Langerhans Cell Histiocytosis: Further Characterizing the Genomic Landscape of LCH.
    McGinnis LM; Nybakken G; Ma L; Arber DA
    Am J Surg Pathol; 2018 Jul; 42(7):885-890. PubMed ID: 29649018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations.
    Pina-Oviedo S; Medeiros LJ; Li S; Khoury JD; Patel KP; Alayed K; Cason RC; Bowman CJ; Yin CC
    Mod Pathol; 2017 May; 30(5):734-744. PubMed ID: 28084334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis.
    Shimizu S; Sakamoto K; Kudo K; Morimoto A; Shioda Y
    Int J Hematol; 2023 Jul; 118(1):119-124. PubMed ID: 37010809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan.
    Hayase T; Saito S; Shioda Y; Imamura T; Watanabe K; Ohki K; Yoshioka T; Oh Y; Kawahara Y; Niijima H; Imashuku S; Morimoto A
    Int J Hematol; 2020 Oct; 112(4):560-567. PubMed ID: 32654047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [BRAF-V600E mutation and its clinical significance in children with Langerhans cell histiocytosis].
    Tang X; Guo X; Sun LY; Ai Y; Yang X; Sun JJ; Wu JR; Gao J
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Apr; 20(4):290-294. PubMed ID: 29658453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent BRAF mutations in Langerhans cell histiocytosis.
    Badalian-Very G; Vergilio JA; Degar BA; MacConaill LE; Brandner B; Calicchio ML; Kuo FC; Ligon AH; Stevenson KE; Kehoe SM; Garraway LA; Hahn WC; Meyerson M; Fleming MD; Rollins BJ
    Blood; 2010 Sep; 116(11):1919-23. PubMed ID: 20519626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case of Pulmonary Langerhans Cell Histiocytosis with BRAF V600E-negative and MAP2K1-posivtive Mutations Presenting as Diffuse Nodules in Chest High-resolution Computed Tomography After Smoking Cessation.
    Li Y; Cai HR; Ma M; Wang LJ; Yang J; Ding JJ; Miao LY
    Chin Med J (Engl); 2016 Jun; 129(11):1384-6. PubMed ID: 27231182
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders.
    Hyman DM; Diamond EL; Vibat CR; Hassaine L; Poole JC; Patel M; Holley VR; Cabrilo G; Lu TT; Arcila ME; Chung YR; Rampal R; Lacouture ME; Rosen N; Meric-Bernstam F; Baselga J; Kurzrock R; Erlander MG; Janku F; Abdel-Wahab O
    Cancer Discov; 2015 Jan; 5(1):64-71. PubMed ID: 25324352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.
    Lamy PJ; Castan F; Lozano N; Montélion C; Audran P; Bibeau F; Roques S; Montels F; Laberenne AC
    J Mol Diagn; 2015 Jul; 17(4):366-73. PubMed ID: 25952101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Value of BRAF VE1 Immunoexpression in Pediatric Langerhans Cell Histiocytosis.
    Phan DAT; Phung GB; Duong TT; Hoang AV; Ngo QD; Trinh DTN; Tran TT
    Fetal Pediatr Pathol; 2022 Aug; 41(4):558-567. PubMed ID: 33295826
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.
    Brown NA; Betz BL; Weigelin HC; Elenitoba-Johnson KS; Lim MS; Bailey NG
    Am J Clin Pathol; 2015 Jan; 143(1):89-99. PubMed ID: 25511147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis.
    Liu H; Osterburg AR; Flury J; Swank Z; McGraw DW; Gupta N; Wikenheiser-Brokamp KA; Kumar A; Tazi A; Inoue Y; Hirose M; McCormack FX; Borchers MT
    JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31961828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors.
    Hayashi Y; Sasaki H; Takeshita S; Nishikawa R; Nishikawa H; Arakawa A; Yamashita Y; Takahashi S; Sugiura-Ogasawara M
    Oncol Rep; 2014 Nov; 32(5):1815-9. PubMed ID: 25174456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.
    Colomba E; Hélias-Rodzewicz Z; Von Deimling A; Marin C; Terrones N; Pechaud D; Surel S; Côté JF; Peschaud F; Capper D; Blons H; Zimmermann U; Clerici T; Saiag P; Emile JF
    J Mol Diagn; 2013 Jan; 15(1):94-100. PubMed ID: 23159108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of BRAF V600E mutation by pyrosequencing.
    Tan YH; Liu Y; Eu KW; Ang PW; Li WQ; Salto-Tellez M; Iacopetta B; Soong R
    Pathology; 2008 Apr; 40(3):295-8. PubMed ID: 18428050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.
    Go H; Jeon YK; Huh J; Choi SJ; Choi YD; Cha HJ; Kim HJ; Park G; Min S; Kim JE
    Histopathology; 2014 Aug; 65(2):261-72. PubMed ID: 24720374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy.
    Wang CJ; Zhu T; Zhao CZ; Cui H; Wang D; Zhao ZJ; Huang XT; Li HL; Liu FF; Zhang R; Li ZG; Cui L
    Pediatr Blood Cancer; 2024 Sep; 71(9):e31099. PubMed ID: 38845144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.